Us Statin Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 4.53 Billion |
 Market Size (Forecast Year) |
USD 5.10 Billion |
 CAGR |
% |
| Major Markets Players |
美国他汀类药物市场，美国他汀类药物市场，按类型（合成他汀类药物和天然他汀类药物）、药物类别（瑞舒伐他汀、阿托伐他汀、氟伐他汀、辛伐他汀、匹伐他汀、洛伐他汀等）、治疗领域（生活方式疾病、心血管疾病等）、性别（男性和女性）、年龄组（成人和儿科）、药物类型（品牌药和仿制药）、给药途径（口服、肠外和其他）、最终用户（医院、诊所、家庭医疗保健、门诊手术中心等）、分销渠道（医院药房、零售药房、网上药房等）划分 - 行业趋势和预测到 2031 年。
美国他汀类药物市场分析和规模
2015 年至 2018 年间，约有 11.4% 的美国成年人总胆固醇偏高。男性（10.5%）和女性（12.1%）之间的高总胆固醇患病率没有显著差异。40-59 岁成年人患病率最高（15.7%），而 20-39 岁成年人患病率仅为 7.5%，60 岁及以上成年人患病率仅为 11.4%。60 岁及以上成年人的总胆固醇偏高患病率也高于 20-39 岁成年人。不同种族或西班牙裔的成年人总胆固醇偏高患病率没有显著差异。
2023 年美国他汀类药物市场规模价值 45.3 亿美元，预计到 2031 年将达到 51 亿美元，2024 年至 2031 年预测期内的复合年增长率为 1.5%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022（可定制为 2016 - 2021） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
类型（合成他汀类药物和天然他汀类药物）、药物类别（瑞舒伐他汀、阿托伐他汀、氟伐他汀、辛伐他汀、匹伐他汀、洛伐他汀等）、治疗领域（生活方式疾病、心血管疾病等）、性别（男性和女性）、年龄组（成人和儿童）、药物类型（品牌药和仿制药）、给药途径（口服、肠胃外等）、最终用户（医院、诊所、家庭医疗保健、门诊手术中心等）、分销渠道（医院药房、零售药房、网上药房等） |
|
覆盖国家 |
我们 |
|
涵盖的市场参与者 |
辉瑞公司（美国）、默克公司（德国）、Kowa Pharmaceuticals America, Inc.（美国）、Dr. Reddy's Laboratories Ltd（印度）、山德士公司（德国）、Novadoz Pharmaceuticals（美国）、Accord（美国）、Althera Pharmaceuticals（美国）、Sun Pharmaceutical Industries Ltd.（印度）、Salerno Pharma（加拿大）、COVIS PHARMA BV（荷兰）、Medicure Inc.（加拿大）、ESPERION THERAPEUTICS, INC.（美国）、Lupin（印度）、Zydus Pharmaceuticals, Inc.（美国）、阿斯利康（英国）、Concord Biotech（印度）、Biocon（印度）、Camber Pharmaceuticals, Inc.（美国）、Ind-Swift Laboratories Ltd.（印度）和 Teva Pharmaceutical Industries Ltd.（以色列） 表单顶部 |
|
市场机会 |
|
市场定义
他汀类药物是一类用于降低血液中胆固醇水平的药物。它们通过抑制酶 HMG-CoA 还原酶起作用，该酶在肝脏胆固醇的生成中起着重要作用。他汀类药物有助于降低 LDL（坏）胆固醇水平，并通过减少胆固醇的生成适度提高 HDL（好）胆固醇水平。这可以帮助降低高胆固醇人群患心脏病和中风的风险。
他汀类药物市场动态
驱动程序
- 增加心血管疾病发病率
心血管疾病 (CVD) 仍然是全球死亡的主要原因，高胆固醇水平是主要风险因素。他汀类药物对于控制胆固醇水平、降低 CVD 风险和改善整体心血管健康至关重要。随着人们对胆固醇管理重要性的认识不断提高，预计对他汀类药物的需求将继续上升并推动市场发展。
- 老龄人口不断增长
全球老龄化人口更容易患心血管疾病，导致对他汀类药物作为预防措施的需求增加。在许多国家，预期寿命的增加和人口老龄化的转变，都推动了市场的增长，老年人口寻求控制胆固醇水平并降低患心脏病的风险。
- 提高认识和筛查计划
公共卫生计划、教育活动和筛查计划提高了人们对高胆固醇风险和早期筛查益处的认识，从而提高了高胆固醇血症的诊断率，增加了对他汀类药物的需求。医疗保健提供者也更积极地筛查患者的胆固醇水平。这种意识的提高推动了市场的增长。
机会
- 个性化医疗
The concept of personalized medicine offers promising opportunities for the market. Advances in genetic testing and pharmacogenomics allow healthcare providers to tailor statin therapy based on individual genetic profiles, optimizing treatment efficacy and reducing the risk of side effects. By investing in research and development in personalized medicine, companies can develop innovative statin therapies that cater to specific patient populations, opening up new market segments and enhancing patient outcomes.
- Digital Health Technologies
The integration of digital health technologies such as mobile apps, wearable devices, and telemedicine platforms can enhance patient engagement and adherence to statin therapy. By leveraging these technologies, companies can develop innovative solutions that improve patient outcomes and differentiate their products. In addition, digital health technologies can provide valuable data insights that help healthcare providers personalize statin therapy, further creating opportunities for market growth.
Restraints/Challenges
- Safety Concerns and Side Effects
While statins are generally well-tolerated, they can cause muscle pain, liver damage, and other adverse effects in some individuals. These safety concerns may lead to patient reluctance to initiate or continue statin therapy, negatively impacting medication adherence and market demand. Safety concerns and the potential for adverse side effects associated with statin therapy present a notable challenge for the market.
- Stringent Regulatory Requirements
Regulatory agencies impose rigorous standards for the approval, manufacturing, and marketing of statin drugs, necessitating substantial investment of time and resources by pharmaceutical companies. Delays in regulatory approvals, compliance issues, and evolving regulatory landscapes can disrupt product launches, limit market access, and increase development costs, which is a challenge for the market growth.
This statin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the statin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In December 2023, AstraZeneca disclosed a potential collaboration with the world's largest pharmaceutical company, aiming to leverage genAI technology to accelerate the discovery of new cancer treatments
- In July 2023, Biocon revealed the successful integration of the Viatris biosimilars business into more than 70 countries in emerging markets. This move has expanded the scale and reach of Biocon's operations
- In June 2023, Aurobindo Pharma announced that its wholly owned subsidiary, Eugia Pharma Specialities Ltd., has entered into a voluntary sub-licensing agreement with the Medicines Patent Pool (MPP) for the development and commercialization of an anti-cancer medication
Statin Market Scope
The U.S. statin market is segmented into type, drug class, therapeutic areas, gender, age group, drug type, route of administration, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Type
- Synthetic Statin
- Natural Statin
Drug Class
- Rouvastatin
- Atorvastatin
- Fluvastatin
- Simvastatin
- Pitavastatin
- Lovastatin
- Others
Therapeutic Areas
- Lifestyle Diseases
- Cardiovascular Diseases
- Others
Gender
- Male
- Female
Age Group
- Adult
- Pediatric
Drug Type
- Branded
- Generics
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospital
- Clinics
- Home Healthcare
- Ambulatory Surgical Centers
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The statin market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for statin market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the statin market. The data is available for historic period 2016-2021.
Competitive Landscape and Statin Market Share Analysis
The statin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the statin market are:
- Pfizer Inc. (U.S.)
- Merck KGaA (Germany)
- Kowa Pharmaceuticals America, Inc. (U.S.)
- Dr. Reddy’s Laboratories Ltd (India)
- Sandoz AG (Germany)
- Novadoz Pharmaceuticals (U.S.)
- Accord (U.S.)
- Althera Pharmaceuticals (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Salerno Pharma (Canada)
- COVIS PHARMA BV (Netherlands)
- Medicure Inc. (Canada)
- ESPERION THERAPEUTICS, INC. (U.S.)
- Lupin (India)
- Zydus Pharmaceuticals, Inc. (U.S.)
- AstraZeneca (U.K.)
- Concord Biotech (India)
- Biocon (India)
- Camber Pharmaceuticals, Inc. (U.S.)
- Ind-Swift Laboratories Ltd. (India)
- Teva Pharmaceutical Industries Ltd. (Israel) Top of Form
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
